Home Cart Sign in  
Chemical Structure| 208538-73-2 Chemical Structure| 208538-73-2

Structure of Micafungin sodium
CAS No.: 208538-73-2

Chemical Structure| 208538-73-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Micafungin sodium is an echinocandin antifungal drug, Micafungin inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls.

Synonyms: FK 463 sodium; Micafungin(sodium salt); Mycamine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Micafungin sodium

CAS No. :208538-73-2
Formula : C56H70N9NaO23S
M.W : 1292.26
SMILES Code : O=S(OC1=CC([C@@H]([C@H](C2NC(C3N(C[C@@H](C3)O)C(C([C@@H](C)O)NC([C@](C[C@H]([C@H](NC(C4N(C[C@@H]([C@@H]4O)C)C(C(NC2=O)[C@@H](CC(N)=O)O)=O)=O)O)O)(NC(C5=CC=C(C=C5)C6=NOC(C7=CC=C(C=C7)OCCCCC)=C6)=O)[H])=O)=O)=O)O)O)=CC=C1O)([O-])=O.[Na+]
Synonyms :
FK 463 sodium; Micafungin(sodium salt); Mycamine
MDL No. :MFCD08067752

Safety of Micafungin sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Candida albicans SC5314 0.005 μg/ml, 0.016 μg/ml, 0.05 μg/ml 1 hour To evaluate the fungicidal effect of micafungin on Candida albicans and its impact on cellular metabolic activity. Results showed that micafungin reduced cell viability and metabolic activity in a dose-dependent manner in YPD medium, with the highest concentration (0.05 μg/ml) causing a 90% reduction in cell viability. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02161-17.
Vero cells 12.5–100 µM 2 days Micafungin significantly inhibited DENV-2 infection in a dose-dependent manner, with the most pronounced activity occurring at a concentration of 100 μM. Pharmaceuticals (Basel). 2021 Apr 7;14(4):338.
Calu-3 cells 55.3 µM (IC50) 24 hours Assessed the antiviral activity of Micafungin in human lung epithelial cells, with an IC50 of 55.3 µM Viruses. 2023 Feb 6;15(2):452.
VeroE6/TMPRSS2 cells 26.1 µM (IC50) 24 hours Evaluated the antiviral activity of Micafungin against SARS-CoV-2, showing an IC50 of 26.1 µM Viruses. 2023 Feb 6;15(2):452.
Candida parapsilosis ≥1 μg/ml 24 hours To evaluate the activity of Micafungin against preformed Candida parapsilosis biofilms, results showed that Micafungin at ≥1 μg/ml significantly inhibited biofilm regrowth. Antimicrob Agents Chemother. 2014 Sep;58(9):5581-4.
Candida albicans ≥2 μg/ml 24 hours To evaluate the activity of Micafungin against preformed Candida albicans biofilms, results showed that Micafungin at ≥2 μg/ml significantly inhibited biofilm regrowth. Antimicrob Agents Chemother. 2014 Sep;58(9):5581-4.
Candida albicans 0.002 to 1.00 mg/L 24 or 48 hours To evaluate the in vitro activity of micafungin against Candida albicans with diverse azole resistance phenotypes. Results showed that azole resistance mechanisms did not affect micafungin MIC values. J Antimicrob Chemother. 2008 Aug;62(2):349-55.
Vero cells 12.5–100 µM 3 days Micafungin significantly reduced viral RNA levels, with a 4.86-log reduction at 100 μM; decreased NS3 protein expression without affecting GAPDH expression; and significantly reduced viral progeny yield. Pharmaceuticals (Basel). 2021 Apr 7;14(4):338.
Candida parapsilosis (CAS-NS isolate 12) 1.0–8.0 µg/mL 3 hours To assess MICA-induced apoptosis in CAS-NS C. parapsilosis biofilms, showing 1.2–2.0-fold increase in ROS accumulation and weaker mitochondrial membrane depolarization. Virulence. 2015;6(4):385-94.
Candida albicans (CAS-NS isolate 6) 1.0–8.0 µg/mL 3 hours To assess MICA-induced apoptosis in CAS-NS C. albicans biofilms, showing 1.2-fold increase in ROS accumulation and weaker mitochondrial membrane depolarization. Virulence. 2015;6(4):385-94.
Candida parapsilosis (CAS-S isolate 7) 1.0–8.0 µg/mL 3 hours To assess MICA-induced apoptosis in CAS-S C. parapsilosis biofilms, showing 4.8–5.4-fold increase in ROS accumulation and significant mitochondrial membrane depolarization. Virulence. 2015;6(4):385-94.
Candida albicans (CAS-S isolate 2) 1.0–8.0 µg/mL 3 hours To assess MICA-induced apoptosis in CAS-S C. albicans biofilms, showing 3.0–4.2-fold increase in ROS accumulation and significant mitochondrial membrane depolarization. Virulence. 2015;6(4):385-94.
Candida parapsilosis (MICA-NS) 0.5-2 mg/L 3 hours Detected apoptosis, results showed 5-30% of cells underwent apoptosis. Microb Cell. 2015 Oct 23;2(11):445-450.
Candida parapsilosis (MICA-S) 0.25-1 mg/L 3 hours Detected apoptosis, results showed 20-52% of cells underwent apoptosis. Microb Cell. 2015 Oct 23;2(11):445-450.
Polymorphonuclear leukocytes (PMN) 0.05 µg/ml to 50 µg/ml 30 minutes To evaluate the effect of micafungin on PMN oxidative burst, results showed that micafungin enhanced the PMN oxidative burst dose dependently. Antimicrob Agents Chemother. 2004 Jul;48(7):2730-2.
Human peritoneal macrophages 0.005 μg/ml, 0.016 μg/ml, 0.05 μg/ml 4 hours To assess the immunomodulatory effect of micafungin-treated Candida albicans on human macrophages. Results demonstrated that micafungin treatment enhanced the macrophage response to C. albicans, increasing the secretion of TNF-α, IL-17A, and IL-10 cytokines. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02161-17.
Aspergillus nidulans ΔmpkA mutant 1 ng/mL 75 minutes To study the role of MpkA in the response to Micafungin-induced cell wall damage, results showed delayed and attenuated gene expression changes in the ΔmpkA mutant compared to the wild type. J Fungi (Basel). 2021 Jun 29;7(7):525.
Aspergillus nidulans wild type strain 1 ng/mL 75 minutes To study the effect of Micafungin on cell wall integrity, results showed significant gene expression changes in the wild type strain, including up-regulation of brlA. J Fungi (Basel). 2021 Jun 29;7(7):525.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Galleria mellonella larvae Staphylococcus aureus infection model Injection 5 mg/kg Single injection, infected after 24 hours To evaluate the effect of Micafungin on larval survival, results showed Micafungin significantly extended the survival time of infected larvae. Mycopathologia. 2016 Feb;181(1-2):17-25

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.77mL

0.15mL

0.08mL

3.87mL

0.77mL

0.39mL

7.74mL

1.55mL

0.77mL

References

 

Historical Records

Categories